연구동향 분석

Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain

김흥덕 정경훈 정운주 김상룡 2016년

논문상세정보
    • 저자 김흥덕 정경훈 정운주 김상룡
    • 제어번호 103473162
    • 학술지명 Journal of medicinal food
    • 권호사항 Vol. 19 No. 4 [ 2016 ]
    • 발행처 한국식품영양과학회
    • 자료유형 학술저널
    • 수록면 374-382
    • 언어 English
    • 출판년도 2016
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain' 의 참고문헌

  • Tyrosine hydroxylase phosphorylation:Regulation and consequences
    Dunkley PR J Neurochem 91 1025-1043 [2004]
  • Transcription-dependent and -independent control of neuronal survival by the PI3KAkt signaling pathway
    Brunet A Curr Opin Neurobiol 11 297-305 [2001]
  • Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo
    Choi SH J Neurosci 23 5877-5886 [2003]
  • Silibinin Attenuates MPP1-Induced Neurotoxicity in the Substantia Nigra In Vivo
    정언주 Journal of Medicinal Food 17 5 599-605 [2014]
  • Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation
    Kim SR J Neurosci Res 88 1537-1548 [2010]
  • Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats
    Fu X Pharmacol Biochem Behav 126 122-130 [2014]
  • Protective mechanisms of flavonoids in Parkinson’s disease
    Magalingam KB Oxid Med Cell Longev 2015 314560- [2015]
  • Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats
    Asano N Asian Pac J Cancer Prev 8 73-76 [2007]
  • Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson’s disease
    Chung YC J Immunol 185 1230-1237 [2010]
  • Nobiletin Protects Dopaminergic Neurons in the 1-Methyl-4-Phenylpyridinium-Treated Rat Model of Parkinson's Disease
    정경훈 Journal of Medicinal Food 18 4 409-414 [2015]
  • Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action
    Park HJ Eur J Neurosci 26 79-89 [2007]
  • Neuroinflammation in Parkinson’s disease:A target for neuroprotection?
    Hirsch EC Lancet Neurol 8 382-397 [2009]
  • Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
    정운주 Experimental Neurobiology 23 2 124-129 [2014]
  • Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson’s disease
    Leem E J Nutr Biochem 25 801-806 [2014]
  • Myricitrin inhibits acrylamidemediated cytotoxicity in human Caco-2 cells by preventing oxidative stress
    Chen W Biomed Res Int 2013 724183- [2013]
  • Myricitrin exhibits antioxidant, antiinflammatory and antifibrotic activity in carbon tetrachlorideintoxicated mice
    Domitrovic R Chem Biol Interact 230 21-29 [2015]
  • Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways
    Qin M Vascul Pharmacol 70 23-34 [2015]
  • Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-jB pathway activation in SH-SY5Y cells
    Wang YH J Mol Neurosci 53 562-570 [2014]
  • Myricitrin alleviates MPP(+)-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells
    Cai Z Biochem Biophys Res Commun 458 227-233 [2015]
  • Myricetin attenuated MPP(+)-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells
    Zhang K Neuropharmacology 61 329-335 [2011]
  • Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: Effects on enzyme stability and activity
    Royo M Arch Biochem Biophys 434 266-274 [2005]
  • Microglial cells and Parkinson’s disease
    Qian L Immunol Res 41 155-164 [2008]
  • Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
    Block ML Prog Neurobiol 76 77-98 [2005]
  • Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo
    Nam JH Neuroreport 25 489-495 [2014]
  • Induction of microglial toll-like receptor 4 by prothrombin kringle-2: A potential pathogenic mechanism in Parkinson’s disease
    Shin WH Sci Rep 5 14764- [2015]
  • Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: Neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson’s disease
    Nam JH Mol Neurobiol 51 487-499 [2015]
  • Gene therapy for neurological disorders: Challenges and future prospects for the use of growth factors for the treatment of Parkinson’s disease
    Manfredsson FP Curr Gene Ther 9 375-388 [2009]
  • Further antinociceptive effects of myricitrin in chemical models of overt nociception in mice
    Cordova MM Neurosci Lett 495 173-177 [2011]
  • Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer’s disease
    Baptista FI ACS Chem Neurosci 5 83-92 [2014]
  • Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons
    최성민 전남의대학술지 50 2 45-51 [2014]
  • Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration
    Kim SR Ann Neurol 70 110-120 [2011]
  • Diagnosis and treatment of Parkinson disease: Molecules to medicine
    Savitt JM J Clin Invest 116 1744-1754 [2006]
  • Continual naringin treatment benefits the recovery of traumatic brain injury in rats through reducing oxidative and inflammatory alterations
    Cui QJ Neurochem Res 39 1254-1262 [2014]
  • Characterization of the RhebmTOR signaling pathway in mammalian cells: Constitutive active mutants of Rheb and mTOR
    Sato T Methods Enzymol 438 307-320 [2008]
  • Cellular survival: A play in three Akts
    Datta SR Genes Dev 13 2905-2927 [1999]
  • Amphetamine-induced appetitive 50-kHz calls in rats: A marker of affect in mania?
    Pereira M Psychopharmacology (Berl) 231 2567-2577 [2014]
  • Alzheimer’s disease and Parkinson’s disease
    Nussbaum RL N Engl J Med 348 1356-1364 [2003]
  • Akt signal transduction dysfunction in Parkinson’s disease
    Timmons S Neurosci Lett 467 30-35 [2009]
  • AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth
    Kim SR Mol Ther 20 275-286 [2012]
  • A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
    Jang SW Proc Natl Acad Sci USA 107 2687-2692 [2010]